MAUSSANG-DETAILLE, DAVID ANDRE BAPTISTE,GEUIJEN, CECILIA ANNA WILHELMINA
申请号:
CA3063849
公开号:
CA3063849A1
申请日:
2018.05.17
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The invention relates to methods of treating of subject that has breast cancer or is at risk of having said cancer, comprising administering to the subject in need thereof a combination of a therapeutically effective amount of an ErbB-2/ErbB-3 bispecific antibody and a therapeutically effective amount of an endocrine therapy drug, wherein the bispecific antibody has an antigen binding site that can bind an extra-cellular part of ErbB-2 and an antigen binding site that can bind an extra-cellular part of ErbB-3; and to means for said method.